Terumo Corporation

GPTKB entity

Properties (57)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition gptkb:Medi-Globe_Technologies
gptkb:Cypress_Medical_Products
Gambro's_blood_transfusion_business
gptkbp:advertising gptkb:Dr._Masahiro_Yamamoto
gptkbp:awards Various industry awards
gptkbp:category diabetes care products
surgical products
cardiovascular products
blood management products
interventional products
gptkbp:CEO Shinjiro Sato
gptkbp:collaborations universities and research institutions
gptkbp:community_involvement disaster relief efforts
volunteer programs
healthcare_education_programs
gptkbp:customerBase hospitals
clinics
laboratories
gptkbp:employees over 25,000
gptkbp:financialPerformance dividend payments
strong market position
consistent growth
gptkbp:founded 1921
gptkbp:founder Sakichi Kawai
gptkbp:global_presence over 160 countries
gptkbp:headquarters gptkb:Tokyo,_Japan
https://www.w3.org/2000/01/rdf-schema#label Terumo Corporation
gptkbp:industry Medical Devices
gptkbp:mission Contribute to society through healthcare.
gptkbp:partnerships various healthcare organizations
gptkbp:patentCitation numerous medical device patents
gptkbp:productionLocation gptkb:Japan
gptkb:United_States
Europe
gptkbp:products Syringes
Cardiovascular Products
IV Catheters
Blood_Collection_Systems
gptkbp:research_focus biologics
drug delivery systems
minimally invasive procedures
gptkbp:researchAndDevelopment focus on innovation
gptkbp:revenue over $5 billion
gptkbp:stockExchange gptkb:Tokyo_Stock_Exchange
4543
gptkbp:subsidiary gptkb:Terumo_Asia_Holdings
gptkb:Terumo_Medical_Corporation
gptkb:Terumo_Europe_N.V.
gptkbp:sustainability_initiatives economic growth
environmental responsibility
social contribution
gptkbp:tactics enhancing customer service
innovation in product development
expansion in emerging markets
gptkbp:vision To be a global leader in medical technology.
gptkbp:website www.terumo.com